Hospital Profile
Name | Cuyuna Regional Medical Center |
---|
Type | Critical Access Hospital |
---|
Location | 320 East Main Street, Crosby, Minnesota |
---|
Ownership | Government - Hospital District or Authority |
---|
Emergency Services | Yes |
---|
Medicare ID (CCN) | 241353 |
Patients' Experience Survey:
Overall Rating of the Hospital:
Willingness to Recommend Hospital:
Yes Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital
Cleanliness of Hospital Environment:
Always Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean
Quietness of Hospital Environment:
Always Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night
Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well
Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well
Responsiveness of Hospital Staff:
Always Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted
Communication about Medicines:
Always Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them
Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home
Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital
NPI Associated with the Hospital:
Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Cuyuna Regional Medical Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
NPI Number | 1538143896 |
Organization Name | CUYUNA REGIONAL MEDICAL CENTER |
Address | 320 E Main St, Crosby, MN 56441 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 218-546-7000 |
News Archive
Transplantation of gene-modified hematopoietic stem cells eliminates cancer: Research
A potent anti-tumor gene introduced into mice with metastatic melanoma has resulted in permanent immune reconfiguration and produced a complete remission of their cancer, according to an article to be published in the December 2010 issue of the Journal of Clinical Investigation.
The president's impassioned health law speech: 'We're going to keep fighting'
President Barack Obama was unusually detailed in his defense of the law, emphasizing the scope of insurance coverage for many Americans.
Genetic makeup helps dictate how physically and mentally healthy you feel
You can blame your parents for your hair that frizzes in high humidity and for your short stature. And now researchers at Saint Louis University School of Public Health say your genetic makeup partly dictates how physically and mentally healthy you feel.
Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting
NewLink Genetics Corporation, a biopharmaceutical company primarily focused on discovering, developing and commercializing immunotherapeutic products in oncology, announced today that the company presented preclinical data for NLG919, a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, at the American Association for Cancer Research 2013 annual meeting.
Read more Medical News
› Verified 8 days ago
Structural Quality Measures:
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Transplantation of gene-modified hematopoietic stem cells eliminates cancer: Research
A potent anti-tumor gene introduced into mice with metastatic melanoma has resulted in permanent immune reconfiguration and produced a complete remission of their cancer, according to an article to be published in the December 2010 issue of the Journal of Clinical Investigation.
The president's impassioned health law speech: 'We're going to keep fighting'
President Barack Obama was unusually detailed in his defense of the law, emphasizing the scope of insurance coverage for many Americans.
Genetic makeup helps dictate how physically and mentally healthy you feel
You can blame your parents for your hair that frizzes in high humidity and for your short stature. And now researchers at Saint Louis University School of Public Health say your genetic makeup partly dictates how physically and mentally healthy you feel.
Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting
NewLink Genetics Corporation, a biopharmaceutical company primarily focused on discovering, developing and commercializing immunotherapeutic products in oncology, announced today that the company presented preclinical data for NLG919, a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, at the American Association for Cancer Research 2013 annual meeting.
Read more News
› Verified 8 days ago